Fresh Tracks Therapeutics, Inc.
FRTXDelisted- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000819050
Fresh Tracks Therapeutics, Inc. was delisted in 2024; its insiders filed their last Form 4 on Jun 11, 2024; no institution reported holding it in 13F filings for Q3 2024; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 0
- Q3 2024
- 13F value
- $0
- Reported value at the end of Q3 2024
- Superinvestors holding
- 0
- At the end of Q3 2024
Superinvestors holding FRTX, Q3 2024
No superinvestor reported holding FRTX at the end of Q3 2024.
Latest insider trades
Open-market purchases and sales by Fresh Tracks Therapeutics, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 11, 2024 (view filing) | Jun 7-10 | 4 days | Exploration Capital, LLC10% Owner | PPurchase | +405.5K | $0.94 | +$381.2K | +30.4%1.74M after | 2 lots |
| May 31, 2024 (view filing) | May 29-31 | 2 days | Exploration Capital, LLC10% Owner | PPurchase | +10.4K | $0.9181 | +$9.58K | +0.8%1.33M after | 3 lots |
| May 23, 2024 (view filing) | May 21-23 | 2 days | Exploration Capital, LLC10% Owner | PPurchase | +22.9K | $0.9097 | +$20.8K | +1.8%1.32M after | 3 lots |
| May 20, 2024 (view filing) | May 16-20 | 4 days | Exploration Capital, LLC10% Owner | PPurchase | +74.6K | $0.9199 | +$68.6K | +6.1%1.30M after | 2 lots |
| May 8, 2024 (view filing) | May 6 | 2 days | Exploration Capital, LLC10% Owner | PPurchase | +320 | $0.89 | +$284.8 | 0.0%1.23M after | |
| May 3, 2024 (view filing) | May 1-3 | 2 days | Exploration Capital, LLC10% Owner | PPurchase | +164.9K | $0.9198 | +$151.7K | +15.5%1.23M after | 3 lots |
| Apr 23, 2024 (view filing) | Apr 19-23 | 4 days | Exploration Capital, LLC10% Owner | PPurchase | +21.5K | $0.9021 | +$19.4K | +2.1%1.06M after | 3 lots |
| Apr 11, 2024 (view filing) | Apr 9-10 | 2 days | Exploration Capital, LLC10% Owner | PPurchase | +3.19K | $0.88 | +$2.81K | +0.3%1.04M after | 2 lots |
| Apr 5, 2024 (view filing) | Apr 3-5 | 2 days | Exploration Capital, LLC10% Owner | PPurchase | +17.4K | $0.91 | +$15.8K | +1.7%1.04M after | 3 lots |
| Apr 1, 2024 (view filing) | Mar 27-Apr 1 | 5 daysLate | Exploration Capital, LLC10% Owner | PPurchase | +54.6K | $0.8999 | +$49.1K | +5.7%1.02M after | 3 lots |
Top 10 13F holders, Q3 2024
The largest institutional positions in Fresh Tracks Therapeutics, Inc. at the end of Q3 2024; share changes are against Q2 2024.
No institution reported holding FRTX in 13F filings for Q3 2024.